Esther Scheirlynck

Esther Scheirlynck

Auto-generated profile, based on publicly available information

Esther Scheirlynck

Cardiology Department, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale , Via Tesserete 48, Lugano CH-6900

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2019 in Open Heart
Verified
Journal Article
Open access
PDF file
ESEsther Scheirlynck
Esther Scheirlynck
LDLars A Dejgaard
Lars A Dejgaard
ESEystein Skjølsvik
Eystein Skjølsvik
OLOyvind H Lie
Oyvind H Lie
AMAndreea Motoc
Andreea Motoc
Kristina Hermann HaugaaKristina Hermann Haugaa
Kristina Hermann Haugaa
Objective Displacement of the mitral valve, mitral annulus disjunction (MAD), is described as a possible aetiology of sudden cardiac death. Stress-induced fibrosis in the mitral valve apparatus has been suggested as the underlying mechanism. We aimed to explore the association between stretch-related and fibrosis-related biomarkers and ventricular arrhythmias in MAD. We hypothesised that soluble suppression of tumourigenicity-2 (sST2) and transforming growth factor-β1 (TGFβ1) are markers of ventricular arrhythmias in patients with MAD. Methods We included patients with ≥1 mm MAD on cardiac MRI. We assessed left ventricular ejection fraction (LVEF) and fibrosis by late gadolinium enhancement (LGE). The occurrence of ventricular arrhythmia, defined as aborted cardiac arrest, sustained or non-sustained ventricular tachycardia, was retrospectively assessed. We assessed circulating sST2 and TGFβ1 levels. Results We included 72 patients with MAD, of which 22 (31%) had ventricular arrhythmias. Patients with ventricular arrhythmias had lower LVEF (60 % (±6) vs 63% (±6), p = 0.04), more frequently papillary muscle fibrosis (14 (64%) vs 10 (20%), p < 0.001) and higher sST2 levels (31.6 ± 10.1 ng/mL vs 25.3 ± 9.2 ng/mL, p = 0.01) compared with those without, while TGFβ1 levels did not differ (p = 0.29). Combining sST2 level, LVEF and papillary muscle fibrosis optimally detected individuals with arrhythmia (area under the curve 0.82, 95% CI 0.73 to 0.92) and improved the risk model (p < 0.05) compared with single parameters. Conclusion Circulating sST2 levels were higher in patients with MAD and ventricular arrhythmias compared with arrhythmia-free patients. Combining sST2, LVEF and LGE assessment improved risk stratification in patients with MAD.

1 January 2020 in International Journal of Cardiology
Verified
Journal Article
Closed access
ESEsther Scheirlynck
Esther Scheirlynck
SMSophie Van Malderen
Sophie Van Malderen
AMAndreea Motoc
Andreea Motoc
ØLØyvind H. Lie
Øyvind H. Lie
CACarlo de Asmundis
Carlo de Asmundis
SDSteven Droogmans
Steven Droogmans

14 April 2021 in Diagnostics
Verified
Journal Article
Open access
PDF file
TPTom De Potter
Tom De Potter
CWCaroline Weytjens
Caroline Weytjens
AMAndreea Motoc
Andreea Motoc
MLMaria-Luiza Luchian
Maria-Luiza Luchian
ESEsther Scheirlynck
Esther Scheirlynck
BCBernard Cosyns
Bernard Cosyns
Three-dimensional echocardiography (3DE) is advised for right ventricular (RV) assessment. Data regarding the optimal acquisition settings and optimization are still scarce. We aimed to evaluate the feasibility, reproducibility and validation of 3DE for RV volume and function assessment, using cardiac magnetic resonance (CMR) as gold standard. Thirty healthy volunteers and 36 consecutive patients were prospectively included. CMR was performed in the latter. Standard apical four-chamber view (A4CV), focused A4CV and modified A4CV were used for 3DE RV acquisition. Feasibility (and the effect of changes in settings) was evaluated. Intra and interobserver analyses were performed by three observers (expert vs. novice). RV parameters by echocardiography were compared to CMR. Feasibility of acquisition was 16.7% for A4CV, 80.0% for focused A4CV and 16.7% for modified A4CV. Changes in settings had no significant influence on feasibility and further analysis. Intraobserver variability was good in both expert and novice, interobserver variability was good between experienced observers. Compared to CMR, 3DE volumes were significantly lower with fair to moderate correlation (EDV: 91.1 ± 24.4 mL vs. 144.3 ± 43.0 mL (p < 0.001), r = 0.653 and ESV: 48.1 ± 16.4 mL vs. 60.4 ± 21.2 mL (p < 0.001), r = 0.530, by multi-beat 3DE and CMR respectively). These findings suggest that standardization is needed in order to implement this technique in clinical practice, thus further studies are required.

1 February 2018 in International Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
KGKris Gillis
Kris Gillis
GBGezim Bala
Gezim Bala
BRBram Roosens
Bram Roosens
Sophie HernotSophie Hernot
Sophie Hernot
IRIsabel Remory
Isabel Remory
BCBernard Cosyns
Bernard Cosyns

2 August 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
SSStefaan Six
Stefaan Six
PTPeter Theuns
Peter Theuns
Pieter LibinPieter Libin
Pieter Libin
ANAnn Nowe
Ann Nowe
LPLuigi Pannone
Luigi Pannone
JBJohan Bilsen
Johan Bilsen
Brugada syndrome (BrS) is a hereditary arrhythmic disease, associated with sudden cardiac death. To date, little is known about the psychosocial correlates and impacts associated with this disease. The aim of this study was to assess a set of patient-reported psychosocial outcomes, to better profile these patients, and to propose a tailored psychosocial care. Patients were recruited at the European reference Centre for BrS at Universitair Ziekenhuis Brussel, Belgium. Recruitment was undertaken in two phases: phase 1 (retrospective), patients with confirmed BrS, and phase 2 (prospective), patients referred for ajmaline testing who had an either positive or negative diagnosis. BrS patients were compared to controls from the general population. Two hundred and nine questionnaires were analysed (144 retrospective and 65 prospective). Collected patient-reported outcomes were on mental health (12 item General Health Questionnaire; GHQ-12), social support (Oslo Social Support Scale), health-related quality of life, presence of Type-D personality (Type-D Scale; DS14), coping styles (Brief-COPE), and personality dimensions (Ten Item Personality Inventory). Results showed higher mental distress (GHQ-12) in BrS patients (2.53 ± 3.03) than in the general population (P < 0.001) and higher prevalence (32.7%) of Type D personality (P < 0.001) in patients with confirmed Brugada syndrome (BrS +). A strong correlation was found in the BrS + group (0.611, P < 0.001) between DS14 negative affectivity subscale and mental distress (GHQ-12). Mental distress and type D personality are significantly more common in BrS patients compared to the general population. This clearly illustrates the necessity to include mental health screening and care as standard for BrS.

1 November 2025 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
MBMarco Bergonti
Marco Bergonti
DFDaniele Faccenda
Daniele Faccenda
Francesco CardinaliFrancesco Cardinali
Francesco Cardinali
TÖTardu Özkartal
Tardu Özkartal
Paolo CompagnucciPaolo Compagnucci
Paolo Compagnucci
GCGiulio Conte
Giulio Conte